Skip to main content
. 2017 Apr 20;16:52. doi: 10.1186/s12933-017-0531-9

Fig. 1.

Fig. 1

Correlations between plasma level of AGE-p and FMD in type 2 diabetic patients with or without coronary artery disease. AGE-p: advanced glycation end product peptides (U/ml); FMD: flow-mediated vasodilatation (%)